Header Logo
Newsletter Podcast
Log In
← Back to all posts

Lasting Relief, Better Outcomes—Plus What PRP Docs Are Doing Differently

Apr 29, 2025
Connect

Highlights

  • Today’s Research Article: Your go-to treatment just got outperformed—see why PRP is leading in joint relief.

  • Questions from the Field: Even if they’re under 65, it’s better to have the ABN signed—every time.

  • Let’s Get Down to Business: Educate, personalize, and document—keys to building a thriving PRP practice.

  • Come Join Us: Train smarter, connect deeper—your next breakthrough starts at a live event.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Platelet-Rich Plasma versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis: A Prospective Randomized Controlled Clinical Trial

Michael-Alexander Malahias, Leonidas Roumeliotis, Vasileios S. Nikolaou, Efstathios Chronopoulos, Ioannis Sourlas, and Georgios C. Babis

Read the full article here.

Summary:

This prospective randomized controlled trial by Malahias et al. compared intra-articular platelet-rich plasma (IA-PRP) injections with corticosteroid injections for treating early to moderate trapeziometacarpal (thumb base) arthritis. Over 12 months, patients receiving IA-PRP experienced significantly better outcomes in pain relief (VAS score), hand function (Q-DASH score), and satisfaction than those treated with corticosteroids. While both treatments showed improvement at 3 months, only the PRP group maintained and improved these benefits at 12 months, with 62.5% of PRP patients reporting mild pain vs. just 12.5% in the steroid group.

The study also demonstrated that patient satisfaction with PRP rose over time, reaching 69% at 12 months compared to only 12.5% in the steroid group. This sustained improvement is attributed to PRP’s biological effects, including anti-inflammatory properties and stimulation of cartilage repair. Given its longer-lasting relief and functional improvement, IA-PRP offers a superior non-surgical option for managing mild to moderate thumb arthritis compared to the short-lived effects of corticosteroids.

Doctor-to-Patient Talking Points for Choosing IA-PRP Over Steroids (with Evidence)

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP vs Steroids: Plantar Fasciitis | OA Outcomes with PRP | Cash Practice Insights
Highlights Today’s Research Article: PRP Beats Steroids for Chronic Heel Pain — And the Results Last! Questions from the Field: PRP Relief Can Last Over a Year — Backed by Real-World Data. Let’s Get Down to Business: Ditch the Burnout — A Cash Practice Can Set You Free. Come Join Us: Learn, Network, and Grow — Join Us Live in Vegas! If this newsletter was forwarded to you and you'd like to r...
Back Pain Breakthrough, Bold Branding, and Big Vegas Events
Highlights Today’s Research Article: Long-Term Relief for Tough Back Pain, Backed by Gold-Standard Research Questions from the Field: "I Get It Done in 37 Minutes" – The PRP Consult Script That Works Let’s Get Down to Business: Brand Strategy is More Than a Logo — It's the Voice of Your Practice Come Join Us: Join Us Live in Vegas for Game-Changing Training & Networking If this newsletter wa...
Science, Secrets, and Strategy for Next-Level PRP Success
Highlights Live Today: Are Culture-Expanded Stem Cells Crossing the Line? Join Us Live for the Debate.  Add to your calendar and tune in at 5PM PST Apple  Google  Office 365  Outlook  Outlook.com  Yahoo   Today’s Research Article: PRP significantly outperformed placebo in reducing knee osteoarthritis pain and improving joint function, with results lasting up to 6 months. Questions from the F...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.